Ascendis Pharma's market cap is currently $12.71B. The company's EPS TTM is $-0.9485144999999999; its P/E ratio is ―; Ascendis Pharma is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
